Company: CRNX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001658247-25-000019
Chunk: 14

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part II, Item 3
Chunk 14
---
 of this Form 10-Q, irrespective of any general incorporation language contained in such filing.

29

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Crinetics Pharmaceuticals, Inc.Date: November 6, 2025By:/s/ R. Scott Struthers, Ph.D.R. Scott Struthers, Ph.D.President and Chief Executive Officer(Principal executive officer)Date: November 6, 2025By:/s/ Tobin SchilkeTobin SchilkeChief Financial Officer(Principal financial and accounting officer)

30